Business Wire

pixitmedia Integrates Ngenea® Data Acceleration Software Into Nara

10.9.2024 14:00:00 CEST | Business Wire | Press release

Share

Push assets faster to a central facility, or for multi-site collaboration, from within the Nara interface; Ngenea for Nara plugin enables a more efficient workflow to maximize productivity, lower costs, boost creativity

pixitmedia, a subsidiary of Kalray (Euronext Growth Paris: ALKAL) specializing in storage and data management solutions for the Media & Entertainment industry, announced that it has integrated its flagship data acceleration platform, Ngenea®, intoFilmLight’s Nara media tool. By enabling media professionals to instantly push assets from point A to B directly through the Nara interface, the new Ngenea for Nara plugin maximizes efficiency in moving image content creation, further streamlining workflows for video and film projects, and freeing time for heightened creativity.

pixitmedia is showcasing Ngenea + Nara at IBC 2024 Amsterdam, September 13 – 16, in its booth at Hall 5.H79.

FilmLight, maker of the Baselight grading system, offers Nara to enable integrated media access, streaming and indexing to streamline workflows and enhance collaboration. Managing file access and security is an ongoing challenge that can constrain efficient workflows and storage resource budgets. With Ngenea integrated into Nara, editors, colorists, visual effects (VFX) artists, cinematographers and directors boost productivity across the most demanding use cases in their workflows.

The Ngenea for Nara plugin enables media professionals to orchestrate production assets between sites and storage classes using Ngenea in real-time, avoiding the delays and bottlenecks that impede efficient workflows. It allows users with Nara to push assets to a central facility instantly – or, when Nara is deployed across multiple locations, to move assets in line with the workflow, or following talent across geographies.

“We launched Nara to empower our customers by boosting their efficiency and creativity, and pixitmedia’s Ngenea for Nara plugin fully supports this mission,” said Sam Lempp, Nara’s head of business development. “We’re delighted to be working with pixitmedia on this Nara and Ngenea integration and to be able to offer our customers yet another efficient workflow tool which will further boost their productivity.”

Built on a foundation of pixitmedia’s underlying software-defined storage platform, Ngenea enables customers to accelerate the processing of their data and streamline complex workflows.

Compatible with both on-prem and cloud environments, Ngenea, enables teams to stream in real-time to Nara’s powerful playback engine or for content delivery either internally or to secure sites of collaborators. Users can automate the process of selecting individual shots, and orchestrate media using Ngenea to any of its supported storage targets, including S3 and most NAS filer, without leaving the Nara interface. Working directly in the web browser, media professionals unlock new levels of agility, backed by the low latency performance needed by Nara to stream and encode in real time to a Nara client.

“pixitmedia is committed to doing whatever it takes to support media & entertainment teams in working at peak efficiency with their preferred solutions, said Eric Baissus, CEO of Kalray, parent to pixitmedia. “The Ngenea for Nara plugin helps media professionals to make the most of their existing technology investments so they can save time, lower costs, and deliver exceptional creative work.

The Ngenea for Nara plugin is available now from pixitmedia. For more information visit www.pixitmedia.com.

ABOUT NARA

Nara, a FilmLight venture, is an integrated media tool offering a streamlined and sophisticated solution for media access, streaming and indexing. Nara can natively decode and play back a wide selection of media without the need to transcode to proxy files. Its advanced indexing system ensures rapid data retrieval while its streaming engine minimises bandwidth usage. It supports on premise and in the cloud storage, provides unparalleled codec support and guarantees uniform and colour-accurate image presentation – offering a comprehensive, efficient, and consistent media review experience which improves workflows and enhances collaboration.

Nara utilizes the technological foundation and expertise of FilmLight and the proven technology that powers its industry-leading Baselight grading platform. For more information, visit: www.nara.stream

ABOUT KALRAY

Kalray is a technology innovator specializing in software and hardware solutions to accelerate data-intensive workflows in Media & Entertainment, High-Performance Computing, and Artificial Intelligence. Our comprehensive product range features Ngenea, a leading data acceleration platform, and accelerated data processing cards for storage and compute.

With Kalray solutions, customers can scale their infrastructures to efficiently meet performance and capacity needs for data-intensive tasks, all without being tied to specific data formats or vendors.

Founded in 2008 as a spin-off from the French CEA research lab, Kalray has corporate and financial backing from notable investors such as Alliance Venture (Renault-Nissan-Mitsubishi), NXP Semiconductors, and Bpifrance. Committed to innovation and excellence, we strive to deliver value to our customers, developers, and the planet through technology and expertise.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240910076987/en/

Contacts

INVESTOR CONTACTSEric BAISSUS

INVESTOR CONTACTSEric BAISSUS
contactinvestisseurs@kalrayinc.com
Phone +33 4 76 18 90 71

ACTUS Finance & Communication
Anne-Pauline PETUREAUX
kalray@actus.fr
Phone + 33 1 53 67 36 72
PRESS CONTACTSPenta STANLEY
communication@kalrayinc.com
Phone +44 7939 877 880

ACTUS Finance & Communication
Serena BONI
sboni@actus.fr
Phone +33 4 72 18 04 92
Mary Kae MARINAC
PR Representative for Kalray
mk@mkmarinac.com
Phone +1 978-685-3136
Caroline Shawley
PR Representative for Nara
carolines@filmlight.ltd.uk
Phone +44 7730 145 759

contactinvestisseurs@kalrayinc.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release

REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit

Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release

In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ

Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release

- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c

Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release

Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til

IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release

Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye